BeyondSpring (BYSI) Revenue & Revenue Breakdown
BeyondSpring Revenue Highlights
0
Latest Revenue (Q)
$500.00K
BeyondSpring Revenue by Period
BeyondSpring Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | - | -100.00% |
2023-12-31 | $1.75M | 29.61% |
2022-12-31 | $1.35M | - |
2021-12-31 | $1.35M | 650.56% |
2020-12-31 | $180.00K | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | - |
BeyondSpring generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
BeyondSpring Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $500.00K | - |
2024-03-31 | $500.00K | 14.16% |
2023-12-31 | $438.00K | - |
2023-09-30 | $438.00K | 0.11% |
2023-06-30 | $437.50K | - |
2023-03-31 | $437.50K | 29.63% |
2022-12-31 | $337.50K | - |
2022-09-30 | $337.50K | -0.15% |
2022-06-30 | $338.00K | - |
2022-03-31 | $338.00K | - |
2021-12-31 | $338.00K | 0.30% |
2021-09-30 | $337.00K | -0.30% |
2021-06-30 | $338.00K | - |
2021-03-31 | $338.00K | 87.78% |
2020-12-31 | $180.00K | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | - |
BeyondSpring generated $500.00K in revenue during Q2 2024, up 0.00% compared to the previous quarter, and up 114.29% compared to the same period a year ago.
BeyondSpring Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ADTX | Aditxt | $133.99M | $1.02K |
EYPT | EyePoint Pharmaceuticals | $43.27M | $11.59M |
SCPH | scPharmaceuticals | $36.33M | $12.15M |
SRZN | Surrozen | $10.65M | $655.00K |
MCRB | Seres Therapeutics | - | - |
ALVR | AlloVir | - | - |
CADL | Candel Therapeutics | - | - |
FBRX | Forte Biosciences | - | - |
INKT | MiNK Therapeutics | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
SLS | SELLAS Life Sciences Group | - | - |
MIST | Milestone Pharmaceuticals | - | - |
BYSI | BeyondSpring | - | $500.00K |
ONCY | Oncolytics Biotech | - | - |
KTTA | Pasithea Therapeutics | - | - |